LFMD
LifeMD Inc
NASDAQ: LFMD · HEALTHCARE · HEALTH INFORMATION SERVICES
$4.68
+5.64% today
Updated 2026-04-30
Market cap
$216.37M
P/E ratio
—
P/S ratio
1.12x
EPS (TTM)
$-0.30
Dividend yield
—
52W range
$3 – $16
Volume
1.3M
LifeMD Inc (LFMD) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$4.68
12-Month target
—
2030 Target
—
Intrinsic (DCF)
$17.58
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $0.1B | $0.1B | $0.2B | $0.2B | $0.2B |
| EPS | — | — | — | — | — |
CAGR applied: — (capped 20%) · P/E: 25.00x (capped 25x) · Margin: 7.40%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.